Based on the primary experimental results, a vaccine developed jointly by Pfizer and BioNTech appears to be effective against the coronavirus.

Coronavirus: the second wave, the second closure

Later than expected by many, but in mid-November, the Hungarian government also decided to try to curb the second wave of the coronavirus epidemic by introducing restrictions. At the time of the decision, 5,000 new infections a day had been identified and the number of deaths from the virus was mostly between 50 and 100 in 24 hours. The first step is partial closure, but how effective it is is questionable. Follow our news!

According to early tests, the vaccine, jointly developed by the US pharmaceutical company Pfizer and the German biotechnology company BioNTech, is more than 90 percent effective, according to Pfizer. The Washington Post.

Pfizer has tested the vaccine with 43,500 people in a total of six countries and no safety concerns have been raised in any of the cases. BBC. Of the subjects, 94 were infected with the coronavirus without prior infection. Nine of them were subjects who received both vaccines, which makes the vaccine developed by the two companies very effective.

The companies now plan to submit an authorization request to the US Food and Drug Administration (FDA) before the end of the month. There are currently about a dozen drugs in the final phase of experiments, but this is the first to show encouraging results.

Pfizer and BioNTech have developed a two-component vaccine whose units will be administered to patients three weeks apart. According to the companies, experiments in the United States, Germany, Brazil, Argentina, South Africa and Turkey show that the drug already provides 90 percent protection seven days after its second administration. Pfizer estimates that if they receive FDA approval, they will be able to deliver 50 million vaccines by the end of the year and 1.3 billion in 2021.

However, in terms of transportation and storage, the most important question is how to implement logistics. This is because the vaccine is currently stored at -80 degrees Celsius. Also, you don’t even know how long your immunity lasts.

If you are interested in the developments, please like the Facebook page in the HVG Tech section.



The number of independent editorial boards of power is steadily decreasing, and those that still exist are trying to stay afloat in a growing headwind. At HVG we persevere, we do not give in to pressure and we bring national and international news every day.

That is why we ask you, our readers, to stand by us, support us, join our membership and renew it!

And we promise to keep doing our best for you in all circumstances!